Clinical trial of tropomyosin inhibitor in children with neuroblastoma in Australia.
Phase of Trial: Phase I
Latest Information Update: 17 Nov 2017
Price : $35 *
At a glance
- Drugs Tropomyosin inhibitors (Primary)
- Indications Neuroblastoma
- Focus Adverse reactions
- 17 Nov 2017 According to a Kazia Therapeutics media release, Novogen changed its name to Kazia Therapeutics.
- 20 May 2014 This trial is expected to start in 2015, according to a Novogen media release.
- 20 May 2014 New trial record